Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16997283rdf:typepubmed:Citationlld:pubmed
pubmed-article:16997283lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:16997283lifeskim:mentionsumls-concept:C0059239lld:lifeskim
pubmed-article:16997283lifeskim:mentionsumls-concept:C1565434lld:lifeskim
pubmed-article:16997283lifeskim:mentionsumls-concept:C0920425lld:lifeskim
pubmed-article:16997283lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:16997283pubmed:issue5lld:pubmed
pubmed-article:16997283pubmed:dateCreated2007-2-2lld:pubmed
pubmed-article:16997283pubmed:abstractTextFocal adhesion kinase (FAK) is a non-receptor tyrosine kinase that plays an important role in signal transduction pathways that are initiated at sites of integrin-mediated cell adhesions and by growth factor receptors. FAK is a key regulator of survival, proliferation, migration and invasion: processes that are all involved in the development and progression of cancer. FAK is also linked to oncogenes at both a biochemical and functional level. Moreover, overexpression and/or increased activity of FAK is common in a wide variety of human cancers, implicating a role for FAK in carcinogenesis. Given the important role of FAK in a large number of processes involved in tumorigenesis, metastasis and survival signalling FAK should be regarded as a potential target in the development of anti-cancer drugs. Therefore, selective inhibitors of FAK need to be developed. Combination of these selective FAK inhibitors with cytotoxic agents could be a very promising anti-cancer therapy.lld:pubmed
pubmed-article:16997283pubmed:languageenglld:pubmed
pubmed-article:16997283pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16997283pubmed:citationSubsetIMlld:pubmed
pubmed-article:16997283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16997283pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16997283pubmed:statusMEDLINElld:pubmed
pubmed-article:16997283pubmed:monthMarlld:pubmed
pubmed-article:16997283pubmed:issn0006-2952lld:pubmed
pubmed-article:16997283pubmed:authorpubmed-author:van de...lld:pubmed
pubmed-article:16997283pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:16997283pubmed:issnTypePrintlld:pubmed
pubmed-article:16997283pubmed:day1lld:pubmed
pubmed-article:16997283pubmed:volume73lld:pubmed
pubmed-article:16997283pubmed:ownerNLMlld:pubmed
pubmed-article:16997283pubmed:authorsCompleteYlld:pubmed
pubmed-article:16997283pubmed:pagination597-609lld:pubmed
pubmed-article:16997283pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:meshHeadingpubmed-meshheading:16997283...lld:pubmed
pubmed-article:16997283pubmed:year2007lld:pubmed
pubmed-article:16997283pubmed:articleTitleFocal adhesion kinase: a potential target in cancer therapy.lld:pubmed
pubmed-article:16997283pubmed:affiliationDivision of Toxicology, Leiden/Amsterdam Center for Drug Research, Leiden University, Gorlaeus Laboratories, 2300 RA Leiden, The Netherlands.lld:pubmed
pubmed-article:16997283pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16997283pubmed:publicationTypeReviewlld:pubmed
pubmed-article:16997283pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16997283lld:pubmed